Maik Haentschel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Renal cell carcinoma (RCC) is an immunogenic tumor for which immunotherapeutic approaches could be associated with clinically relevant responses. It was recently shown, that induction of T-cell responses against multiple tumor-associated antigen (TAA) epitopes results in prolonged overall survival in RCC patients. In 2003-2005, we performed a phase I/II(More)
  • 1